Atomo Diagnostics Limited (ASX:AT1)

John Kelly
MD & CEO
Market Cap (AUD): 128.49M
Sector: Health Care
Last Trade (AUD): 0.32 +0.01 (+1.59%)
Tab Bar

1. About

Atomo Diagnostics (ASX:AT1) is a global leader in the design of medical devices for blood-based rapid testing for professional use and self-testing.

Atomo’s innovative rapid diagnostic test (RDT) platforms simplify procedures, mitigate common user errors, and enhance test performance. Their unmatched usability has won the respect of frontline healthcare providers worldwide, and has made Atomo the OEM partner of choice for diagnostic companies wanting to enhance their RDT product offerings.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk